Join us for part 2 of BrainStorm’s interview with Dr. Suzanne LeBlang, Director of Clinical Relations at Focused Ultrasound Foundation (www.fusfoundation.org). Host Meryl Comer and Dr. LeBlang discuss eligibility criteria and applications for the ground-breaking technology of focused ultrasound – a non-invasive procedure for treating tremors in Parkinson’s disease and those newly diagnosed with Alzheimer’s disease. This technological advancement can target and treat tissue deep within the brain, enhance drug delivery, and facilitate the removal of amyloid plaques. As featured on CBS 60 Minutes, patients are awake during this transformational procedure.  You won’t want to miss part 2 of this interview! Support the show